Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses

Hepatitis E virus (HEV), an enterically transmitted pathogen, is one of the major causes of acute hepatitis in humans worldwide, being responsible for outbreaks and epidemics in regions with suboptimal sanitary conditions, in many of which it is endemic. In industrialized countries, hepatitis E is rarely reported, but recent studies have revealed quite high human seroprevalence rates and the possibility of porcine zoonotic transmission. There is currently no specific therapy or licensed vaccine against HEV infection, and little is known about its intracellular growth cycle, as until very recently no efficient cell culture system has been available. In the present study, vaccinia viruses have been used to express recombinant HEV ORF2 proteins, allowing the study of their glycosylation patterns and subcellular localization. Furthermore, the expressed proteins have been shown to be good antigens for diagnostic purposes and to elicit high and long-lasting specific anti-HEV titers of antibodies in mice that are passively transferred to the offspring by both transplacental and lactation routes. © 2012, American Society for Microbiology.

Saved in:
Bibliographic Details
Main Authors: Jiménez de Oya, N., Escribano-Romero, E., Blázquez, A. B., Lorenzo, M., Martín-Acebes, M. A., Blasco, R., Saiz, J. C.
Format: journal article biblioteca
Language:eng
Published: 2012
Online Access:http://hdl.handle.net/20.500.12792/2184
Tags: Add Tag
No Tags, Be the first to tag this record!
id dig-inia-es-20.500.12792-2184
record_format koha
spelling dig-inia-es-20.500.12792-21842020-12-15T09:46:46Z Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses Jiménez de Oya, N. Escribano-Romero, E. Blázquez, A. B. Lorenzo, M. Martín-Acebes, M. A. Blasco, R. Saiz, J. C. Hepatitis E virus (HEV), an enterically transmitted pathogen, is one of the major causes of acute hepatitis in humans worldwide, being responsible for outbreaks and epidemics in regions with suboptimal sanitary conditions, in many of which it is endemic. In industrialized countries, hepatitis E is rarely reported, but recent studies have revealed quite high human seroprevalence rates and the possibility of porcine zoonotic transmission. There is currently no specific therapy or licensed vaccine against HEV infection, and little is known about its intracellular growth cycle, as until very recently no efficient cell culture system has been available. In the present study, vaccinia viruses have been used to express recombinant HEV ORF2 proteins, allowing the study of their glycosylation patterns and subcellular localization. Furthermore, the expressed proteins have been shown to be good antigens for diagnostic purposes and to elicit high and long-lasting specific anti-HEV titers of antibodies in mice that are passively transferred to the offspring by both transplacental and lactation routes. © 2012, American Society for Microbiology. 2020-10-22T12:39:12Z 2020-10-22T12:39:12Z 2012 journal article http://hdl.handle.net/20.500.12792/2184 10.1128/JVI.00610-12 eng Attribution-NonCommercial-ShareAlike 4.0 International http://creativecommons.org/licenses/by-nc-sa/4.0/ open access
institution INIA ES
collection DSpace
country España
countrycode ES
component Bibliográfico
access En linea
databasecode dig-inia-es
tag biblioteca
region Europa del Sur
libraryname Biblioteca del INIA España
language eng
description Hepatitis E virus (HEV), an enterically transmitted pathogen, is one of the major causes of acute hepatitis in humans worldwide, being responsible for outbreaks and epidemics in regions with suboptimal sanitary conditions, in many of which it is endemic. In industrialized countries, hepatitis E is rarely reported, but recent studies have revealed quite high human seroprevalence rates and the possibility of porcine zoonotic transmission. There is currently no specific therapy or licensed vaccine against HEV infection, and little is known about its intracellular growth cycle, as until very recently no efficient cell culture system has been available. In the present study, vaccinia viruses have been used to express recombinant HEV ORF2 proteins, allowing the study of their glycosylation patterns and subcellular localization. Furthermore, the expressed proteins have been shown to be good antigens for diagnostic purposes and to elicit high and long-lasting specific anti-HEV titers of antibodies in mice that are passively transferred to the offspring by both transplacental and lactation routes. © 2012, American Society for Microbiology.
format journal article
author Jiménez de Oya, N.
Escribano-Romero, E.
Blázquez, A. B.
Lorenzo, M.
Martín-Acebes, M. A.
Blasco, R.
Saiz, J. C.
spellingShingle Jiménez de Oya, N.
Escribano-Romero, E.
Blázquez, A. B.
Lorenzo, M.
Martín-Acebes, M. A.
Blasco, R.
Saiz, J. C.
Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses
author_facet Jiménez de Oya, N.
Escribano-Romero, E.
Blázquez, A. B.
Lorenzo, M.
Martín-Acebes, M. A.
Blasco, R.
Saiz, J. C.
author_sort Jiménez de Oya, N.
title Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses
title_short Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses
title_full Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses
title_fullStr Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses
title_full_unstemmed Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses
title_sort characterization of hepatitis e virus recombinant orf2 proteins expressed by vaccinia viruses
publishDate 2012
url http://hdl.handle.net/20.500.12792/2184
work_keys_str_mv AT jimenezdeoyan characterizationofhepatitisevirusrecombinantorf2proteinsexpressedbyvacciniaviruses
AT escribanoromeroe characterizationofhepatitisevirusrecombinantorf2proteinsexpressedbyvacciniaviruses
AT blazquezab characterizationofhepatitisevirusrecombinantorf2proteinsexpressedbyvacciniaviruses
AT lorenzom characterizationofhepatitisevirusrecombinantorf2proteinsexpressedbyvacciniaviruses
AT martinacebesma characterizationofhepatitisevirusrecombinantorf2proteinsexpressedbyvacciniaviruses
AT blascor characterizationofhepatitisevirusrecombinantorf2proteinsexpressedbyvacciniaviruses
AT saizjc characterizationofhepatitisevirusrecombinantorf2proteinsexpressedbyvacciniaviruses
_version_ 1758004905313828864